CA2274893A1 - Excipient pour liberer de l'apomorphine dans la cavite buccale - Google Patents
Excipient pour liberer de l'apomorphine dans la cavite buccale Download PDFInfo
- Publication number
- CA2274893A1 CA2274893A1 CA002274893A CA2274893A CA2274893A1 CA 2274893 A1 CA2274893 A1 CA 2274893A1 CA 002274893 A CA002274893 A CA 002274893A CA 2274893 A CA2274893 A CA 2274893A CA 2274893 A1 CA2274893 A1 CA 2274893A1
- Authority
- CA
- Canada
- Prior art keywords
- active substance
- pharmaceutical preparation
- apomorphine
- preparation according
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'invention concerne une préparation médicamenteuse à forme galénique plate, de type film, papier ou hostie, servant à administrer et à libérer des principes actifs dans la cavité buccale, qui se caractérise par une teneur en apomorphine ou en un de ses sels appropriés sur le plan thérapeutique.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19652268.4 | 1996-12-16 | ||
DE19652268A DE19652268C2 (de) | 1996-12-16 | 1996-12-16 | Arzneizubereitung für die Freisetzung von Apomorphin in der Mundhöhle |
PCT/EP1997/006529 WO1998026763A1 (fr) | 1996-12-16 | 1997-11-21 | Excipient pour liberer de l'apomorphine dans la cavite buccale |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2274893A1 true CA2274893A1 (fr) | 1998-06-25 |
Family
ID=7814859
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002274893A Abandoned CA2274893A1 (fr) | 1996-12-16 | 1997-11-21 | Excipient pour liberer de l'apomorphine dans la cavite buccale |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0959875A1 (fr) |
JP (1) | JP2001506612A (fr) |
KR (1) | KR20000057627A (fr) |
AU (1) | AU746373B2 (fr) |
CA (1) | CA2274893A1 (fr) |
DE (1) | DE19652268C2 (fr) |
NO (1) | NO992944L (fr) |
WO (1) | WO1998026763A1 (fr) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7910132B2 (en) | 1998-09-24 | 2011-03-22 | Orexo Ab | Pharmaceutical composition for the treatment of acute disorders |
CN101005824B (zh) * | 2004-06-17 | 2012-05-30 | 高露洁-棕榄公司 | 口腔护理薄膜 |
US9044475B2 (en) | 2009-06-12 | 2015-06-02 | Cynapsus Therapeutics, Inc. | Sublingual apomorphine |
US9283219B2 (en) | 2010-12-16 | 2016-03-15 | Cynapsus Therapeutics, Inc. | Sublingual films |
US10449146B2 (en) | 2015-04-21 | 2019-10-22 | Sunovion Pharmaceuticals Inc. | Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6596298B2 (en) | 1998-09-25 | 2003-07-22 | Warner-Lambert Company | Fast dissolving orally comsumable films |
US6291471B1 (en) | 1998-12-17 | 2001-09-18 | Abb Holdings, Inc. | Use of apomorphine for the treatment of organic erectile dysfunction in males |
WO2000038536A2 (fr) | 1998-12-23 | 2000-07-06 | Mount Sinai School Of Medicine Of New York University | Inhibiteurs de la reaction a la saveur amere |
US7314716B2 (en) | 1999-11-19 | 2008-01-01 | Mount Sinai School Of Medicine | Gustducin γ subunit materials and methods |
US7067116B1 (en) | 2000-03-23 | 2006-06-27 | Warner-Lambert Company Llc | Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1 |
USRE44145E1 (en) | 2000-07-07 | 2013-04-09 | A.V. Topchiev Institute Of Petrochemical Synthesis | Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties |
US8206738B2 (en) | 2001-05-01 | 2012-06-26 | Corium International, Inc. | Hydrogel compositions with an erodible backing member |
US20050215727A1 (en) | 2001-05-01 | 2005-09-29 | Corium | Water-absorbent adhesive compositions and associated methods of manufacture and use |
ATE438418T1 (de) | 2001-05-01 | 2009-08-15 | Av Topchiev Inst Petrochemical | Hydrogel-zusammensetzungen |
US8541021B2 (en) | 2001-05-01 | 2013-09-24 | A.V. Topchiev Institute Of Petrochemical Synthesis | Hydrogel compositions demonstrating phase separation on contact with aqueous media |
US8840918B2 (en) | 2001-05-01 | 2014-09-23 | A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences | Hydrogel compositions for tooth whitening |
DE10252726B4 (de) * | 2002-11-13 | 2008-05-08 | Lts Lohmann Therapie-Systeme Ag | Mehrschichtiges transmucosales therapeutisches System |
AU2003277788A1 (en) * | 2002-11-14 | 2004-06-03 | Givaudan Sa | Edible film containing food acid |
KR100945741B1 (ko) * | 2003-01-16 | 2010-03-05 | 부광약품 주식회사 | 염산아포모르핀을 함유하는 구강스프레이 제제 |
CN1929819B (zh) * | 2004-01-30 | 2012-02-29 | 考里安国际公司 | 递送活性剂的快速溶解膜 |
WO2010083035A2 (fr) | 2009-01-14 | 2010-07-22 | Corium International, Inc. | Administration transdermique de tamsulosine |
US10806703B2 (en) * | 2012-01-20 | 2020-10-20 | Lts Lohmann Therapie-System Ag | Transmucosal administration system for a pharmaceutical drug |
MX2016006087A (es) * | 2013-11-11 | 2016-08-12 | Impax Laboratories Inc | Formulaciones de desintegracion rapida y metodos de uso. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3972995A (en) * | 1975-04-14 | 1976-08-03 | American Home Products Corporation | Dosage form |
DE2746414A1 (de) * | 1977-10-15 | 1979-04-26 | Gerlach Eduard Chem Fab | Mittel zum dosieren von stoffen und verfahren zu seiner herstellung |
DE69514794T2 (de) * | 1994-04-22 | 2000-07-27 | Pentech Pharmaceuticals Inc | Sublinguale dosierungsformen enthaltend apomorphin zur verwendung bei der behandlung von erektiler dysfunktion |
FR2732896B1 (fr) * | 1995-04-11 | 1997-06-13 | Prographarm Lab | Forme pharmaceutique transdermique pour l'administration percutanee de l'apomorphine |
-
1996
- 1996-12-16 DE DE19652268A patent/DE19652268C2/de not_active Expired - Fee Related
-
1997
- 1997-11-21 KR KR1019990705422A patent/KR20000057627A/ko not_active Application Discontinuation
- 1997-11-21 WO PCT/EP1997/006529 patent/WO1998026763A1/fr not_active Application Discontinuation
- 1997-11-21 AU AU56547/98A patent/AU746373B2/en not_active Ceased
- 1997-11-21 EP EP97952795A patent/EP0959875A1/fr not_active Withdrawn
- 1997-11-21 CA CA002274893A patent/CA2274893A1/fr not_active Abandoned
- 1997-11-21 JP JP52593498A patent/JP2001506612A/ja active Pending
-
1999
- 1999-06-16 NO NO992944A patent/NO992944L/no not_active Application Discontinuation
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7910132B2 (en) | 1998-09-24 | 2011-03-22 | Orexo Ab | Pharmaceutical composition for the treatment of acute disorders |
US8454996B2 (en) | 1998-09-24 | 2013-06-04 | Orexo Ab | Pharmaceutical composition for the treatment of acute disorders |
US8512747B2 (en) | 1998-09-24 | 2013-08-20 | Orexo Ab | Pharmaceutical composition for the treatment of acute disorders |
CN101005824B (zh) * | 2004-06-17 | 2012-05-30 | 高露洁-棕榄公司 | 口腔护理薄膜 |
US9669018B2 (en) | 2009-06-12 | 2017-06-06 | Sunovion Pharmaceuticals Inc. | Sublingual apomorphine |
US9669020B2 (en) | 2009-06-12 | 2017-06-06 | Sunovion Pharmaceuticals Inc. | Sublingual apomorphine |
US9326981B2 (en) | 2009-06-12 | 2016-05-03 | Cynapsus Therapeutics, Inc. | Sublingual apomorphine |
US10420763B2 (en) | 2009-06-12 | 2019-09-24 | Sunovion Pharmaceuticals Inc. | Sublingual apomorphine |
US9044475B2 (en) | 2009-06-12 | 2015-06-02 | Cynapsus Therapeutics, Inc. | Sublingual apomorphine |
US9669021B2 (en) | 2009-06-12 | 2017-06-06 | Sunovion Pharmaceuticals Inc. | Sublingual apomorphine |
US9669019B2 (en) | 2009-06-12 | 2017-06-06 | Sunovion Pharmaceuticals Inc. | Sublingual apomorphine |
EP2952191B1 (fr) | 2009-06-12 | 2018-08-22 | Sunovion Pharmaceuticals Inc. | Apomorphine sublinguale |
US9283219B2 (en) | 2010-12-16 | 2016-03-15 | Cynapsus Therapeutics, Inc. | Sublingual films |
US10285953B2 (en) | 2010-12-16 | 2019-05-14 | Sunovion Pharmaceuticals Inc. | Sublingual films |
US9427412B2 (en) | 2010-12-16 | 2016-08-30 | Cynapsus Therapeutics, Inc. | Sublingual films |
US11419769B2 (en) | 2010-12-16 | 2022-08-23 | Sunovion Pharmaceuticals Inc. | Sublingual films |
US10449146B2 (en) | 2015-04-21 | 2019-10-22 | Sunovion Pharmaceuticals Inc. | Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa |
US10959943B2 (en) | 2015-04-21 | 2021-03-30 | Sunovion Pharmaceuticals Inc. | Methods of treating Parkinson's disease by administration of apomorphine to an oral mucosa |
Also Published As
Publication number | Publication date |
---|---|
NO992944D0 (no) | 1999-06-16 |
AU746373B2 (en) | 2002-04-18 |
DE19652268C2 (de) | 2000-06-29 |
NO992944L (no) | 1999-06-16 |
WO1998026763A1 (fr) | 1998-06-25 |
DE19652268A1 (de) | 1998-06-18 |
KR20000057627A (ko) | 2000-09-25 |
AU5654798A (en) | 1998-07-15 |
EP0959875A1 (fr) | 1999-12-01 |
JP2001506612A (ja) | 2001-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU746373B2 (en) | Active substance carrier for releasing apomorphine into the buccal cavity | |
AU741362B2 (en) | Flat medicament preparation for the application and release of buprenorphine or a pharmacologically comparable substance in the buccal cavity, and method of producing the same | |
KR100597806B1 (ko) | 통증 및 중독 치료에 사용하기 위해 구강에서 옥시코돈또는 이와 유사한 유효성분의 경점막 투여용 편평한 의약제제 | |
RU2342953C2 (ru) | Трансмукозная система доставки лекарственных средств | |
RU2403043C2 (ru) | Подъязычная таблетка, покрытая оболочкой | |
Bredenberg et al. | In vitro and in vivo evaluation of a new sublingual tablet system for rapid oromucosal absorption using fentanyl citrate as the active substance | |
EP2805716B1 (fr) | Composition pharmaceutique comprenant la buprénorphine ayant une action rapide | |
RU2316316C2 (ru) | Плоский или пластинчатый лекарственный препарат с исправленным вкусом | |
TWI282286B (en) | Pharmaceutical composition a bilayer tablet having an immediate release phase of paracetamol and a sustained release phase of paracetamol | |
AU2018281944B2 (en) | Quickly disintegrating foam wafer with high mass per unit area | |
Ponchel | Formulation of oral mucosal drug delivery systems for the systemic delivery of bioactive materials | |
EP0181650A1 (fr) | Comprimés dispersibles enrobés par compression | |
US20070190117A1 (en) | Buccal formulations of galanthamine and uses thereof | |
KR20050021003A (ko) | 대마 활성 성분의 투여용 필름 형상의 점막접착성 투여 제형 | |
MXPA99005551A (es) | Preparacion medicinal plana para fijacion y liberacion de buprenorfina o de una substancia farmacologicamente comparable en la cavidad bucal y procedimiento para su preparacion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued | ||
FZDE | Discontinued |
Effective date: 20031121 |